UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 22, 2022
Accession Number:
0001640334-22-002680
Submission Type:
POS AM
CIK:
0001348362
Company Name:
Lexaria Bioscience Corp.
File Number:
333-250326